Literature DB >> 30182728

Postoperative Monitoring Following Adenotonsillectomy for Severe Obstructive Sleep Apnea.

Cecil Bryant Rhodes1, Anas Eid1, Grant Muller1, Amanda Kull1, Tim Head2, Madhu Mamidala1, Boyd Gillespie1, Anthony Sheyn1.   

Abstract

INTRODUCTION: Patients undergoing adenotonsillectomy (T&A) for severe obstructive sleep apnea (OSA) are usually admitted for observation, and many surgeons use the intensive care unit (ICU) for observation due to the risk of postsurgical airway obstruction. Given the limited resources of the pediatric ICU (PICU), there is a push to better define the patients who require postoperative monitoring in the PICU for monitoring severe OSA.
METHODS: Forty-five patients were evaluated. Patients who had cardiac or craniofacial comorbidities were excluded. Patients undergoing T&A for severe OSA were monitored in the postanesthesia care unit (PACU) postoperatively. If patients required supplemental oxygen or developed hypoxia while in the PACU within the 3-hour monitoring period, they were admitted to the PICU.
RESULTS: Overall, 16 of 45 patients were admitted to the ICU for monitoring. Patients with an Apnea-Hypopnea Index (AHI) >50 or with an oxygen nadir <80% were significantly more likely to be admitted to the PICU. The mean AHI of patients admitted to the PICU was 40.5, and the mean oxygen nadir was 69.9%. Patients younger than 2 years were significantly more likely to be admitted to the PICU.
CONCLUSION: Based on the data presented here and academy recommendations, not all patients with severe OSA require ICU monitoring.

Entities:  

Keywords:  OSAHS surgery; obstructive sleep apnea (OSA); otolaryngology; pediatric OSA surgical treatment; pediatric tonsillectomy and adenoidectomy; rhinology

Mesh:

Year:  2018        PMID: 30182728     DOI: 10.1177/0003489418794700

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  1 in total

1.  Postoperative respiratory complications in children with obstructive sleep apnoea syndrome.

Authors:  Pálma Benedek; Fanni Keserü; Gabriella Kiss; Zsolt Bella; László Rovó; Gábor Katona; András Bikov; Balázs Csoma; Zsófia Lázár
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.